Morse Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Morse Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$303K	Hold	5,000	–	–	0.06%	142
2025 Q4	$270K	Sell	5,000 -800	-14%	-$38.5K	0.05%	145
2025 Q3	$262K	Hold	5,800	–	–	0.05%	143
2025 Q2	$268K	Sell	5,800 -12,920	-69%	-$634K	0.06%	141
2025 Q1	$1.14M	Sell	18,720 -47,572	-72%	-$2.77M	0.29%	75
2024 Q4	$3.75M	Buy	66,292 +56,292	+563%	+$3.15M	0.86%	35
2024 Q3	$517K	Buy	10,000 +2,000	+25%	+$93.8K	0.11%	126
2024 Q2	$332K	Hold	8,000	–	–	0.08%	129
2024 Q1	$434K	Hold	8,000	–	–	0.11%	110
2023 Q4	$410K	Hold	8,000	–	–	0.12%	111
2023 Q3	$464K	Hold	8,000	–	–	0.15%	110
2023 Q2	$512K	Sell	8,000 -1,000	-11%	-$67.1K	0.16%	112
2023 Q1	$624K	Sell	9,000 -7,945	-47%	-$560K	0.21%	100
2022 Q4	$1.22M	Sell	16,945 -100	-0.6%	-$7.54K	0.44%	66
2022 Q3	$1.21M	Sell	17,045 -16,525	-49%	-$1.2M	0.46%	63
2022 Q2	$2.58M	Buy	33,570 +22,070	+192%	+$1.68M	0.83%	39
2022 Q1	$840K	Hold	11,500	–	–	0.21%	102
2021 Q4	$717K	Sell	11,500 -5,975	-34%	-$350K	0.16%	105
2021 Q3	$1.03M	Hold	17,475	–	–	0.25%	90
2021 Q2	$1.17M	Sell	17,475 -500	-3%	-$32.6K	0.28%	81
2021 Q1	$1.14M	Sell	17,975 -12,560	-41%	-$781K	0.29%	77
2020 Q4	$1.89M	Sell	30,535 -85	-0.3%	-$5.23K	0.53%	50
2020 Q3	$1.85M	Buy	30,620 +2,300	+8%	+$138K	0.59%	44
2020 Q2	$1.67M	Sell	28,320 -13,695	-33%	-$819K	0.59%	44
2020 Q1	$2.34M	Buy	42,015 +16,999	+68%	+$1.04M	1.12%	25
2019 Q4	$1.61M	Buy	25,016 +12,281	+96%	+$703K	0.55%	57
2019 Q3	$646K	Hold	12,735	–	–	0.24%	82
2019 Q2	$578K	Sell	12,735 -115	-0.9%	-$5.36K	0.17%	95
2019 Q1	$613K	Buy	12,850 +100	+0.8%	+$4.98K	0.18%	91
2018 Q4	$663K	Hold	12,750	–	–	0.24%	78
2018 Q3	$792K	Sell	12,750 -6,700	-34%	-$398K	0.21%	90
2018 Q2	$1.08M	Sell	19,450 -3,500	-15%	-$189K	0.29%	80
2018 Q1	$1.45M	Buy	22,950 +12,050	+111%	+$775K	0.4%	62
2017 Q4	$668K	Buy	10,900 +100	+0.9%	+$6.25K	0.19%	93
2017 Q3	$688K	Hold	10,800	–	–	0.21%	90
2017 Q2	$602K	Sell	10,800 -400	-4%	-$21.8K	0.2%	89
2017 Q1	$609K	Buy	+11,200	New	+$614K	0.21%	95

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Morse Asset Management's BMY Position: Q1 2026 in Review

Morse Asset Management held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 5,000 shares worth $303K. The position accounts for 0.06% of the portfolio, ranked #142.

Morse Asset Management first reported a position in BMY in Q1 2017 and has held it in 37 quarters since. The position peaked at $3.75M in Q4 2024. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Morse Asset Management held 5,000 shares of Bristol-Myers Squibb worth $303K as of Q1 2026.
Morse Asset Management left its Bristol-Myers Squibb share count unchanged in Q1 2026.
Bristol-Myers Squibb made up 0.06% of Morse Asset Management's portfolio in Q1 2026, its #142 holding.
Morse Asset Management first reported a position in Bristol-Myers Squibb in Q1 2017 and has held it in 37 quarters since.
Morse Asset Management's Bristol-Myers Squibb position peaked at $3.75M in Q4 2024.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Morse Asset Management's 13F filing for Q1 2026, filed 14 May 2026.